未登录 分享 收藏
Evaluating surrogates for overall survival in the adjuvant treatment of bladder cancer with chemotherapy 评估化疗在膀胱癌辅助治疗中总体生存率的替代指标 Sternberg, C. N.; Squifflet, P.; Saad, E. D.; Burdett, S.; Fisher, D.; Kurt, M.; Teitsson, S.; May, J. R.; Patel, M. Y.; Stoeckle, M.; Torti, F.; Cote, R.; Ruggeri, E. M.; Zhegalik, A.; Tierney, J. F.; Collette, L.; Burzykowski, T.; Buyse, M. 分享 收藏
分享 收藏
分享 收藏
Rationale and Design of the COPERNIC Trial: A Study of On-treatment ctDNA Changes in Chemo-refractory Colorectal Cancer Patients Assaf, Irene; Bregni, Giacomo; Anthoine, Geraldine; Aparicio, Thomas; Artru, Pascal; Ben Abdelghani, Meher; Buyse, Marc; Chibaudel, Benoist; Coart, Elisabeth; Diaz, Marie; Evrard, Camille; Geboes, Karen; Ghiringhelli, Francois; Puleo, Francesco; Raimbourg, Judith; Vandamme, Timon; van den Eynde, Marc; Hendlisz, Alain; Sclafani, Francesco 分享 收藏
分享 收藏
分享 收藏
Interim efficacy analysis of REGINA, a phase II trial of neoadjuvant regorafenib (Rego), nivolumab (Nivo), and short-course radiotherapy (SCRT) in stage II-III rectal cancer (RC) Sclafani, F.; Bregni, G.; Assaf, I.; Puleo, F.; Vergauwe, P.; Prenen, H.; Diaz, M.; Gokburun, Y.; Sanchez, A. Veron; Anthoine, G.; Moretti, L.; Galdon, M. Gomez; Liberale, G.; Martinive, P.; Geboes, K.; Carrasco, J.; van den Eynde, M.; van Laethem, J-L.; Buyse, M. E.; Hendlisz, A. 分享 收藏
Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer Xie, W.; Ravi, P.; Buyse, M.; Halabi, S.; Kantoff, P.; Sartor, O.; Soule, H.; Clarke, N.; Dignam, J.; James, N.; Fizazi, K.; Gillessen, S.; Mottet, N.; Murphy, L.; Parulekar, W.; Sandler, H.; Tombal, B.; Williams, S.; Sweeney, C. J. 分享 收藏
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database Karapetis, C. S.; Liu, H.; Sorich, M. J.; Pederson, L. D.; Van Cutsem, E.; Maughan, T.; Douillard, J. Y.; O'Callaghan, C. J.; Jonker, D.; Bokemeyer, C.; Sobrero, A.; Cremolini, C.; Chibaudel, B.; Zalcberg, J.; Adams, R.; Buyse, M.; Peeters, M.; Yoshino, T.; de Gramont, A.; Shi, Q. 分享 收藏
分享 收藏
分享 收藏
ICECaP-2: Validation of metastasis-free survival (MFS) as a surrogate for overall survival (OS) in localized prostate cancer (LPC) in a more contemporary era Xie, W.; Ravi, P.; Buyse, M. E.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Soule, H. R.; Clarke, N.; Collette, L.; Dignam, J.; James, N. D.; Fizazi, K.; Gillessen, S.; Mottet, N.; Murphy, L. R.; Parulekar, W. R.; Sandler, H.; Tombal, B.; Williams, S.; Sweeney, C. 分享 收藏
Assessing PSA Halabi, S.; Roy, A.; Guo, S.; Rydzewska, L.; Godolphin, P. J.; Parmar, M. K.; Hussain, M.; Tangen, C.; Thompson, I. M.; Carducci, M. A.; Smith, M. R.; Morris, M. J.; Gravis, G.; Dearnaley, D.; Verhagen, P.; Goto, T.; James, N. D.; Buyse, M. E.; Tierney, J.; Sweeney, C. 分享 收藏
分享 收藏
Refining risk stratification in patients undergoing radiotherapy (RT) and long-term (lt) ADT for high-risk/locally advanced prostate cancer (HR/LA-PC): An individual patient data (IPD) analysis of randomized controlled trials (RCTs) from the ICECaP consortium Ravi, P.; Xie, W.; Buyse, M. E.; Halabi, S.; Kantoff, P. W.; Sartor, O.; Attard, G.; Clarke, N. W.; D'Amico, A.; Dignam, J.; James, N. D.; Fizazi, K.; Gillessen, S.; Parulekar, W. R.; Sandler, H.; Spratt, D.; Sydes, M. R.; Tombal, B.; Williams, S.; Sweeney, C. 分享 收藏
分享 收藏
A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration Jackson, Timothy L.; Slakter, Jason; Buyse, Marc; Wang, Kun; Dugel, Pravin U.; Wykoff, Charles C.; Boyer, David S.; Gerometta, Michael; Baldwin, Megan E.; Price, Clare F. 分享 收藏
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial 以曲妥珠单抗为基础的HER2-positive乳腺癌辅助治疗后neratinib的总生存期 (ExteNET): 一项随机、双盲、安慰剂对照的3期试验 Holmes, Frankie A.; Moy, Beverly; Delaloge, Suzette; Chia, Stephen K. L.; Ejlertsen, Bent; Mansi, Janine; Iwata, Hiroji; Gnant, Michael; Buyse, Marc; Barrios, Carlos H.; Silovski, Tajana; Separovic, Robert; Bashford, Anna; Zotano, Angel Guerrero; Denduluri, Neelima; Patt, Debra; Gokmen, Erhan; Gore, Ira; Ii, John W. Smith; Loibl, Sibylle; Masuda, Norikazu; Tomasevic, Zorica; Petrakova, Katarina; DiPrimeo, Daniel; Wong, Alvin; Martin, Miguel; Chan, Arlene 分享 收藏
分享 收藏
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
